Asensus Surgical, Inc. Stock price
Equities
ASXC
US04367G1031
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.233 USD | -0.43% | -17.18% | -27.28% |
Mar. 21 | Asensus Surgical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | Transcript : Asensus Surgical, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Financials (USD)
Sales 2024 * | 12.3M | Sales 2025 * | 22.21M | Capitalization | 63.64M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -55M | EV / Sales 2024 * | 5.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.87 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-1.61
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.03% |
Latest transcript on Asensus Surgical, Inc.
1 day | +1.74% | ||
1 week | -18.75% | ||
Current month | -22.00% | ||
1 month | -23.28% | ||
3 months | -33.97% | ||
6 months | -17.78% | ||
Current year | -26.62% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Fernando
CEO | Chief Executive Officer | 52 | 15-07-31 |
Director of Finance/CFO | 57 | 20-08-23 | |
Motti Frimer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 04-12-31 | |
Kevin J. Hobert
BRD | Director/Board Member | 59 | 21-07-21 |
William Starling
FOU | Founder | 70 | 06-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.2333 | -0.30% | 679 598 |
24-03-27 | 0.234 | +1.74% | 1,134,033 |
24-03-26 | 0.23 | -4.56% | 1,612,959 |
24-03-25 | 0.241 | +0.37% | 4,604,515 |
24-03-22 | 0.2401 | -14.25% | 3,750,512 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.62% | 63.64M | |
+3.10% | 197B | |
+1.11% | 71.22B | |
+12.40% | 53.77B | |
+19.12% | 48.75B | |
+6.87% | 44.22B | |
+11.92% | 28.85B | |
+11.73% | 27.62B | |
+10.13% | 28.57B | |
+19.96% | 26.73B |